Related Experiment Video
Updated: Aug 6, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene,
Yoshio Hosoi1, Leon N Kapp, John P Murnane
1Department of Radiation Research, Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan. hosoi@m.u-tokyo.ac.jp
Abstract:
The ataxia-telangiectasia group D complementing gene, ATDC, is located at 11q23, where loss of heterozygosity (LOH) is frequently observed in many kinds of cancers including breast cancer. Underexpression of ATDC in breast and prostate cancer has been reported using serial analysis of gene expression (SAGE) and DNA microarray analysis. We previously reported that SV-40-transformation down-regulates the expression of ATDC. In the present study, we investigated the roles of ATDC in carcinogenesis. First, we investigated the expression of ATDC in 11 cancer cell lines. No detectable transcript was observed in 4 tumor cell lines, and no ATDC protein was detected in 8 tumor cell lines. We transfected ATDC expression vector into Saos-2 and BT-549 that lacked detectable mRNA and protein expression of ATDC. Colony-forming efficiency in soft agar was significantly suppressed in all of the ATDC transfectants. These results suggest that suppressed ATDC expression is associated with malignant phenotype.
Insights
The ataxia-telangiectasia group D complementing gene (ATDC) plays a role in preventing cancer. Suppressed ATDC expression correlates with a malignant phenotype, suggesting its tumor-suppressive function.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The ataxia-telangiectasia group D complementing gene (ATDC) is located at 11q23, a region frequently affected by loss of heterozygosity (LOH) in various cancers, including breast cancer.
- Previous studies indicate ATDC underexpression in breast and prostate cancers and that SV-40 transformation down-regulates ATDC expression.
Purpose of the Study:
- To investigate the role of ATDC in the process of carcinogenesis.
- To examine ATDC expression levels in various cancer cell lines.
Main Methods:
- Assessed ATDC expression (mRNA and protein) in 11 cancer cell lines.
- Transfected ATDC expression vectors into Saos-2 and BT-549 cell lines lacking detectable ATDC.
- Evaluated the effect of ATDC re-expression on colony-forming efficiency in soft agar.
Main Results:
- No detectable ATDC transcript was observed in 4 tumor cell lines.
- No ATDC protein was detected in 8 tumor cell lines.
- Transfection of ATDC significantly suppressed colony-forming efficiency in soft agar in the recipient cell lines.
Conclusions:
- Suppressed expression of ATDC is associated with a malignant cellular phenotype.
- These findings suggest that ATDC functions as a tumor suppressor gene.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Anaphase Promoting Complex
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

